Clinical Trial Update: Clinical Trial of Chemotherapy, Oregovomab and Nivolumab in Patients With Epithelial Cancer of Ovarian, Tubal or Peritoneal Origin [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating chemotherapy, oregovomab, and nivolumab in patients with epithelial ovarian cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epithelial Ovarian Cancer

Drugs mentioned

• Chemotherapy (chemotherapy)
• Oregovomab (oregovomab)
• nivolumab (nivolumab)

Snippet

Sponsor: National Cancer Centre, Singapore | Conditions: Epithelial Ovarian Cancer | Phase 1, Phase 2 | Status: UNKNOWN